Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 4/20 | 1.00 |
| ▸ | TCF4 | P15884 | 3/20 | 1.00 |
| ▸ | CREBBP | Q92793 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 15/20 | 0.39 |
| ▸ | CLPP | Q16740 | 2/20 | 0.39 |
| ▸ | TCF7 | P36402 | 2/20 | 0.39 |
| ▸ | BCL9 | O00512 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15647716 | 1.00 | CTNNB1 (1.00) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL15837002 | 1.00 | CTNNB1 (1.00) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL30674063 | 1.00 | CTNNB1 (1.00) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL1591981 | 1.00 | CTNNB1 (1.00) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL29372747 | 1.00 | CTNNB1 (1.00) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL1592416 | 0.99 | CTNNB1 (0.99) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL1559610 | 0.94 | CTNNB1 (0.89) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL15476709 | 0.93 | CTNNB1 (0.87) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| SCHEMBL15477080 | 0.92 | CTNNB1 (0.85) | CTNNB1TCF4CREBBPCYP3A4CLPP | |
| Phosphoric Acid SCHEMBL25382778 | 0.92 | CTNNB1 (0.84) | CTNNB1TCF4CREBBPCYP3A4CLPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3784240-B1 | WNT6 AS GLIOBLASTOMA ONCOGENIC BIOMARKER, AND USES OF INHIBITORS THEREOF FOR TREATING WNT6-OVEREXPRESSING GLIOBLASTOMA | UNIV DO MINHO (PT) | 2023-09-20 | — | — | EP | disclosed |